BridgeMD
New treatment option for Homonymous Hemianopsia
Official title Neuromodulation Through Multisensory Stimulation for Visual Field Deficits in the Subacute Stage of Disease
ClinicalTrials.gov ID: NCT07358832
What this study is testing
- What it's testing
- Homonymous visual field defects (HVFDs) after acquired brain injuries affect daily life by impairing reading, navigation, and social activities, often impacting anxiety and depression. Spontaneous recovery is rare.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- \- Presence of subacute acquired brain injury (\< 3 months) with HVFD according to Neurophthalmological evaluation
You likely can't join if
- Presence of hemispatial neglect (indexed by pathological asymmetries on paper-and-pencil tests)
- Disorders of conjugated eye movements
- Other neurological disorders (e.g., dementia)
- Exclusion criteria for brain stimulation (i.e., epilepsy or family history of epilepsy; implanted electrodes, stimulators, pacemakers, infusion...
The study team makes the final eligibility decision.
Where it's taking place
- Milan, Lombardy, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Milan, Lombardy, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.